Phase Ib/II study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (JK1201I) as second‐line monotherapy for patients with small‐cell lung cancer
Article in Cancer Medicine (September 2024)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
Article in Cancer Medicine (September 2024)
Book chapter (May 2024)
Article in Frontiers in Immunology (January 2024)